Vitamin C therapy ameliorates vascular endothelial dysfunction in treated patients with homocystinuria

Journal of Inherited Metabolic Disease

Volumn 25, Issue 2, 2002, Pages 107-118

  Pullin, C H ^a   Bonham, J R ^b   McDowell, I F W ^a   Lee, P J ^c   Powers, H J ^d   Wilson, J F ^a   Lewis, M J ^a   Moat, S J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^d NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; ANTIOXIDANT; ASCORBIC ACID; BETAINE; CHOLESTEROL; CREATININE; CYANOCOBALAMIN; CYSTATHIONINE BETA SYNTHASE; CYSTEINE; FOLIC ACID; GLUCOSE; GLYCERYL TRINITRATE; HOMOCYSTEINE; METHIONINE; PYRIDOXINE; TRIACYLGLYCEROL; 5-METHYLTETRAHYDROFOLATE; HOMOCYSTINE; NITRIC OXIDE; TETRAHYDROFOLIC ACID DERIVATIVE;

ADOLESCENT; ADULT; AGE; AMINO ACID BLOOD LEVEL; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTERY THROMBOSIS; ARTERY WALL; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; ENDOTHELIUM LESION; FEMALE; GENDER; HOMOCYSTINURIA; HUMAN; HYPERHOMOCYSTEINEMIA; LONG TERM CARE; MALE; PATIENT COMPLIANCE; PROGNOSIS; RISK FACTOR; SHORT COURSE THERAPY; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION; BLOOD; BLOOD FLOW VELOCITY; BLOOD PRESSURE; DRUG EFFECT; HEART RATE; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASODILATATION;

ADULT; ASCORBIC ACID; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BRACHIAL ARTERY; ENDOTHELIUM, VASCULAR; FEMALE; HEART RATE; HOMOCYSTINE; HOMOCYSTINURIA; HUMAN; MALE; METHIONINE; NITRIC OXIDE; NITROGLYCERIN; TETRAHYDROFOLATES; VASODILATION; HUMANS;

EID: 0035987991     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015672625913     Document Type: Article

References (34)

1. Close relationship of endothelial function in the human coronary and peripheral circulations
2. Putative mechanisms for vascular damage by homocysteine
3. Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults
4. High dose ascorbate supplementation fails to affect plasma homocyst(e)ine levels in patients with coronary heart disease
5. Endothelial dysfunction: Does it matter? Is it reversible?
6. Impaired endothelial function occurs in systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents
7. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinaemia: An effect reversible with vitamin C therapy
8. 12) administration on endothelial dysfunction induced by post-methionine load hyperhomocysteinemia
9. Neutrophil superoxide anion-generating capacity, endothelial function and oxidative stress in chronic heart failure: Effects of short-and long-term vitamin C therapy
10. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease
11. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers
12. L-Ascorbic acid potentiates endothelial nitric oxide synthase by chemical stabilization of tetrahydrobiopterin
13. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure
14. Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin
15. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations
16. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo
17. Homocysteine-induced inhibition of endothelium-dependent relaxation in the rabbit aorta: A role for superoxide anions
18. Low whole-blood S-adenosylmethionine and correlation between 5-methyltetrahydrofolate and homocysteine in coronary artery disease
19. Recommended approaches for the laboratory diagnosis and monitoring of patients with hyperhomocysteinaemia
20. Elevated plasma homocysteine elicits an increase in antioxidant enzyme activity
21. The role of plasma aminothiols as a component of the plasma antioxidant defence system and its relevance to homocysteine-mediated vascular disease
22. The natural history of homocystinuria due to cystathionine beta-synthase deficiency
23. Disorders of transsulfuration
24. Endothelial control of arterial distensibilty is impaired in chronic heart failure
25. The pathogenesis of atherosclerosis: A perspective for the 1990s
26. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease
27. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
28. Vitamin C improves endothelium-dependent vasodilatation by restoring nitric oxide activity in essential hypertension
29. Endothelium-dependent flow-mediated vasodilatation in coronary and brachial arteries in suspected coronary artery disease
30. Vitamin C improves endothelium-dependent vasodilatation in patients with non-insulin dependent diabetes mellitus
31. Vitamin C improves endothelium-dependent vasodilatation in forearm resistance vessels of humans with hypercholesterolemia
32. Endothelial dysfunction by acute hyperhomocyst(e)inaemia: Restoration by folic acid
33. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans
34. Vascular complications of severe hyperhomocysteinaemia in patients with homocystinuria due to cysthathionine β-synthase deficiency: Effects of homocysteine-lowering therapy